L-carnitine treatment in glutaric aciduria type I

Area of Science:

• Biochemistry
• Metabolic Disorders
• Nutritional Science

Background:

• Organic acidurias are a group of inherited metabolic disorders.
• These conditions can disrupt normal metabolic pathways, potentially affecting nutrient requirements.
• L-carnitine plays a crucial role in fatty acid metabolism.

Observation:

• A patient diagnosed with type I glutaric aciduria presented with significantly low serum total L-carnitine levels (8.5 microM compared to a normal range of 54.4 +/- 14.2 microM).
• Following one month of L-carnitine supplementation, serum levels of both free and total L-carnitine normalized.
• The acyl-to-total L-carnitine ratio improved to 0.18, and fractional clearance rates for free and acylcarnitine increased fourfold.

Findings:

• L-carnitine treatment effectively restored normal L-carnitine levels in this patient.
• The normalization of acylcarnitine ratios and clearance rates indicates improved metabolic function.
• Acetylcarnitine constituted a lower than normal proportion of recovered acylcarnitine, suggesting specific metabolic alterations.

Implications:

• This case suggests that patients with organic acidurias, particularly type I glutaric aciduria, may have an increased requirement for L-carnitine.
• Carnitine deficiency could be a complicating factor in organic acidurias, impacting overall metabolic health.
• Further research is warranted to explore the prevalence and management of L-carnitine deficiency in organic aciduria patients.